Interleukin-33 modulates the expression of human β-defensin 2 in human primary keratinocytes and may influence the susceptibility to bacterial superinfection in acute atopic dermatitis

IL-33: a Janus cytokine: Table 1

(2012) F Y Liew   ANNALS OF THE RHEUMATIC DISEASES

IL-33: A Novel Danger Signal System in Atopic Dermatitis

(2012) Ferda Cevikbas et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

IL-33 and ST2 in Atopic Dermatitis: Expression Profiles and Modulation by Triggering Factors

(2012) Terhi Savinko et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Mast Cells Respond to Cell Injury through the Recognition of IL-33

(2012) Carolina Lunderius-Andersson et al.   Frontiers in Immunology

IL-1F5, -F6, -F8, and -F9: A Novel IL-1 Family Signaling System That Is Active in Psoriasis and Promotes Keratinocyte Antimicrobial Peptide Expression

(2011) A. Johnston et al.   JOURNAL OF IMMUNOLOGY

IL-33 and Airway Inflammation

(2011) Keisuke Oboki et al.   Allergy Asthma & Immunology Research

IL-33 family members and asthma – bridging innate and adaptive immune responses

(2010) Clare M. Lloyd   CURRENT OPINION IN IMMUNOLOGY

Enhanced Expression and Secretion of Antimicrobial Peptides in Atopic Dermatitis and after Superficial Skin Injury

(2010) Jürgen Harder et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

EGFR and IL-1 Signaling Synergistically Promote Keratinocyte Antimicrobial Defenses in a Differentiation-Dependent Manner

(2010) Andrew Johnston et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

The cytokine interleukin-33 mediates anaphylactic shock

(2009) P. N. Pushparaj et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA